NLR
Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are the intracellular pattern recognition receptors (PRRs) that trigger innate immunity and provide protection to the host against invading pathogens. NLRs are divided into three major subgroups: NALP (N-terminal, nucleotide-binding oligomerization domain [NACHT], leucine-rich repeat [LRR], and PYD-containing proteins), NOD (NACHT, LRR, and caspase activation and recruitment domain [CARD]-containing proteins), and NAIP (neuronal apoptosis inhibitor proteins). The NOD subgroup constituted of five receptor proteins, of which NOD1 is a cytosolic signaling host PRR comprising of the CARD at the central NACHT domain and a series of LRR domains at the C-terminal that recognize the pathogen-associated molecular patterns (PAMPs) and activates downstream signaling. Upon ligand recognition and binding, the downstream signaling adaptor molecule receptor-interacting serine/threonine kinase (RICK) is recruited which results in NF-κB phosphorylation and induction of cytokine gene expression[1].
[1] B.R. Sahoo et al. Activation of nucleotide-binding oligomerization domain 1 (NOD1) receptor signaling in Labeo rohita by iE-DAP and identification of ligand-binding key motifs in NOD1 by molecular modeling and docking. Appl. Biochem. Biotechnol. 2013, 170, 1282-1309.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3877 | BMS-986299 | First-in-class NLRP3 agonist | €140.00 | |
3475 | Dapansutrile | Selective and orally active NLRP3 inflammasome inhibitor | €70.00 | |
3839 | JC2-11 | Inhibitor of the NLRP3/NLRC4/AIM2 inflammasomes | €120.00 | |
4052 | MCC950 sodium salt | Highly potent and selective NLRP3 inflammasome inhibitor | €120.00 | |
1888 | ML 130 | Potent and selective inhibitor of NOD1 (NLRC1) | €95.00 | |
4261 | NP3-146 sodium salt | NLRP3 inhibitor | Recently added | €110.00 |